The correlation between each of these checkpoints and their tumour‐secreted ligands would be interesting to explore, as well as relating each immune checkpoint to the T‐cell subset it is most highly expressed in, and whether there are any underlying associations with common mutations such as BRAF. The gene discussed is BRAF; the disease is neoplasm.